FUNDING

To support data collection and processing and the implementation of the international genome-wide association study (GWAS), INHERENT is co-financed by:

Public Funds

Private Funds

Institutional/National Initiatives

The following private sources* are supporting INHERENT:

Agios Pharmaceuticals Inc

*Pharmaceutical companies will not be granted access to any personal data that allows patient identification. Data shared with pharmaceutical companies will follow the same established policies for the transfer of data to other third parties, such as researchers or patient advocacy groups.